BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37844631)

  • 1. Prophylactic effects of arketamine, but not hallucinogenic psychedelic DOI nor non-hallucinogenic psychedelic analog lisuride, in lipopolysaccharide-treated mice and mice exposed to chronic restrain stress.
    Liu G; Ma L; Qu Y; Wan X; Xu D; Zhao M; Murayama R; Hashimoto K
    Pharmacol Biochem Behav; 2023 Dec; 233():173659. PubMed ID: 37844631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid antidepressant-like effect of non-hallucinogenic psychedelic analog lisuride, but not hallucinogenic psychedelic DOI, in lipopolysaccharide-treated mice.
    Qu Y; Chang L; Ma L; Wan X; Hashimoto K
    Pharmacol Biochem Behav; 2023 Jan; 222():173500. PubMed ID: 36476377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role of gut-brain axis on prophylactic actions of arketamine in male mice exposed to chronic restrain stress.
    Ma L; Eguchi A; Liu G; Qu Y; Wan X; Murayama R; Mori C; Hashimoto K
    Pharmacol Biochem Behav; 2024 May; 238():173736. PubMed ID: 38401573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT
    Sekssaoui M; Bockaert J; Marin P; Bécamel C
    Neuropsychopharmacology; 2024 Mar; 49(4):747-756. PubMed ID: 38212441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A key role of miR-132-5p in the prefrontal cortex for persistent prophylactic actions of (R)-ketamine in mice.
    Ma L; Wang L; Chang L; Shan J; Qu Y; Wang X; Wan X; Fujita Y; Hashimoto K
    Transl Psychiatry; 2022 Sep; 12(1):417. PubMed ID: 36171191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT
    de la Fuente Revenga M; Jaster AM; McGinn J; Silva G; Saha S; González-Maeso J
    ACS Chem Neurosci; 2022 Aug; 13(16):2436-2448. PubMed ID: 35900876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.
    Karaki S; Becamel C; Murat S; Mannoury la Cour C; Millan MJ; Prézeau L; Bockaert J; Marin P; Vandermoere F
    Mol Cell Proteomics; 2014 May; 13(5):1273-85. PubMed ID: 24637012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based discovery of nonhallucinogenic psychedelic analogs.
    Cao D; Yu J; Wang H; Luo Z; Liu X; He L; Qi J; Fan L; Tang L; Chen Z; Li J; Cheng J; Wang S
    Science; 2022 Jan; 375(6579):403-411. PubMed ID: 35084960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychedelic-Induced Serotonin 2A Receptor Downregulation Does Not Predict Swim Stress Coping in Mice.
    Pędzich BD; Medrano M; Buckinx A; Smolders I; De Bundel D
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The G protein biased serotonin 5-HT2A receptor agonist lisuride exerts anti-depressant drug-like activities in mice.
    Pogorelov VM; Rodriguiz RM; Roth BL; Wetsel WC
    Front Mol Biosci; 2023; 10():1233743. PubMed ID: 37900918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The G protein biased serotonin 5-HT 2A receptor agonist lisuride exerts anti-depressant drug-like activities in mice.
    Pogorelov VM; Rodriguiz RM; Roth BL; Wetsel WC
    bioRxiv; 2023 Jun; ():. PubMed ID: 37333376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin 2A Receptor (5-HT
    Duan W; Cao D; Wang S; Cheng J
    Chem Rev; 2024 Jan; 124(1):124-163. PubMed ID: 38033123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Jiaotaiwan on depressive-like behavior in mice after lipopolysaccharide administration.
    Zhe Q; Sulei W; Weiwei T; Hongyan L; Jianwei W
    Metab Brain Dis; 2017 Apr; 32(2):415-426. PubMed ID: 27796565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential signaling signatures evoked by DOI versus lisuride stimulation of the 5-HT
    Banerjee AA; Vaidya VA
    Biochem Biophys Res Commun; 2020 Oct; 531(4):609-614. PubMed ID: 32814630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 5-HT
    Głuch-Lutwin M; Sałaciak K; Pytka K; Gawalska A; Jamrozik M; Śniecikowska J; Kołaczkowski M; Depoortère RY; Newman-Tancredi A
    Behav Brain Res; 2023 Feb; 438():114207. PubMed ID: 36368443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasting effects of DOI and lisuride on impulsive decision-making in delay discounting task.
    Jiang K; Liu X; Su R
    Psychopharmacology (Berl); 2022 Nov; 239(11):3551-3565. PubMed ID: 36107207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex.
    González-Maeso J; Yuen T; Ebersole BJ; Wurmbach E; Lira A; Zhou M; Weisstaub N; Hen R; Gingrich JA; Sealfon SC
    J Neurosci; 2003 Oct; 23(26):8836-43. PubMed ID: 14523084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of rapid antidepressant effects of Kir4.1 channel inhibitors in a chronic social defeat stress model: Comparison with (R)-ketamine.
    Xiong Z; Zhang K; Ishima T; Ren Q; Ma M; Pu Y; Chang L; Chen J; Hashimoto K
    Pharmacol Biochem Behav; 2019 Jan; 176():57-62. PubMed ID: 30502360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role of splenic heme biosynthesis pathway in the persistent prophylactic actions of arketamine in lipopolysaccharide-treated mice.
    Ma L; Wang L; Qu Y; Wan X; Hashimoto K
    Transl Psychiatry; 2023 Jul; 13(1):269. PubMed ID: 37491335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression.
    Zhang JC; Yao W; Dong C; Yang C; Ren Q; Ma M; Han M; Hashimoto K
    Psychopharmacology (Berl); 2015 Dec; 232(23):4325-35. PubMed ID: 26337614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.